Filter by faculty:

Found 1 matching student topics

Displaying 1–1 of 1 results

Improving platinum-based chemotherapy by targeting drug metabolism in lung cancer

Lung cancer is the deadliest cancer accounting for 18.4% of all cancer-related deaths. Platinum-based chemotherapy remains a key treatment option for most people living with this disease, either as adjuvant therapy or in combination with immunotherapy. However, resistance to therapy is a significant issue in the treatment of lung cancer. Novel therapeutic strategies combined with predictive biomarkers chemotherapy response are needed to transform the clinical management of NSCLC.Our published work has identified novel biomarkers and druggable proteins from deregulated protein …

Study level
Master of Philosophy, Honours
School of Biomedical Sciences
Research centre(s)
Centre for Genomics and Personalised Health

Page 1 of 1